Qiu et al. found that BUB1B promoted hepatocellular carcinoma progression via activating the mTORC1 signaling pathway, and the oncogenic effect of BUB1B can be impaired when the mTORC1 signaling pathway was inhibited 25. The gene discussed is BUB1B; the disease is hepatocellular carcinoma.